Difference between revisions of "Ciprofloxacin (Cipro)"
Jump to navigation
Jump to search
(Created page with "A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. Category:Drug index Category:Antibacte...") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | ||
− | + | ==Also known as== | |
− | + | *'''Brand name:''' Cipro | |
− | [[Category:Drugs FDA approved in 1987]] | + | [[Category:Drugs]] |
+ | [[Category:Oral medications]] | ||
+ | [[Category:Intravenous medications]] | ||
+ | |||
+ | [[Category:Fluoroquinolone]] | ||
+ | |||
+ | [[Category:FDA approved in 1987]] |
Latest revision as of 19:44, 30 July 2018
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties.
Also known as
- Brand name: Cipro